Linking γ-aminobutyric acid A receptor to epidermal growth factor receptor pathways activation in human prostate cancer

Weijuan Wu, Qing Yang, Kar Ming Fung, Mitchell R. Humphreys, Lacy S. Brame, Amy Cao, Yu Ting Fang, Pin Tsen Shih, Bradley P. Kropp, Hsueh Kung Lin

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Neuroendocrine (NE) differentiation has been attributed to the progression of castration-resistant prostate cancer (CRPC). Growth factor pathways including the epidermal growth factor receptor (EGFR) signaling have been implicated in the development of NE features and progression to a castration-resistant phenotype. However, upstream molecules that regulate the growth factor pathway remain largely unknown. Using androgen-insensitive bone metastasis PC-3 cells and androgen-sensitive lymph node metastasis LNCaP cells derived from human prostate cancer (PCa) patients, we demonstrated that γ-aminobutyric acid A receptor (GABAAR) ligand (GABA) and agonist (isoguvacine) stimulate cell proliferation, enhance EGF family members expression, and activate EGFR and a downstream signaling molecule, Src, in both PC-3 and LNCaP cells. Inclusion of a GABAAR antagonist, picrotoxin, or an EGFR tyrosine kinase inhibitor, Gefitinib (ZD1839 or Iressa), blocked isoguvacine and GABA-stimulated cell growth, trans-phospohorylation of EGFR, and tyrosyl phosphorylation of Src in both PCa cell lines. Spatial distributions of GABAAR α1 and phosphorylated Src (Tyr416) were studied in human prostate tissues by immunohistochemistry. In contrast to extremely low or absence of GABAAR α1-positive immunoreactivity in normal prostate epithelium, elevated GABAAR α1 immunoreactivity was detected in prostate carcinomatous glands. Similarly, immunoreactivity of phospho-Src (Tyr416) was specifically localized and limited to the nucleoli of all invasive prostate carcinoma cells, but negative in normal tissues. Strong GABAAR α1 immunoreactivity was spatially adjacent to the neoplastic glands where strong phospho-Src (Tyr416)-positive immunoreactivity was demonstrated, but not in adjacent to normal glands. These results suggest that the GABA signaling is linked to the EGFR pathway and may work through autocrine or paracine mechanism to promote CRPC progression.

Original languageEnglish
Pages (from-to)69-79
Number of pages11
JournalMolecular and Cellular Endocrinology
Volume383
Issue number1-2
DOIs
StatePublished - 1 Dec 2013

Fingerprint

Aminobutyrates
Epidermal Growth Factor Receptor
Prostatic Neoplasms
Chemical activation
Castration
Prostate
Ligands
Androgens
Intercellular Signaling Peptides and Proteins
Cells
Tissue
Neoplasm Metastasis
Picrotoxin
Phosphorylation
Molecules
Cell proliferation
Cell growth
Epidermal Growth Factor
Protein-Tyrosine Kinases
Spatial distribution

Keywords

  • γ-Aminobutyric acid receptor
  • Epidermal growth factor
  • Prostate cancer
  • Src

Cite this

Wu, Weijuan ; Yang, Qing ; Fung, Kar Ming ; Humphreys, Mitchell R. ; Brame, Lacy S. ; Cao, Amy ; Fang, Yu Ting ; Shih, Pin Tsen ; Kropp, Bradley P. ; Lin, Hsueh Kung. / Linking γ-aminobutyric acid A receptor to epidermal growth factor receptor pathways activation in human prostate cancer. In: Molecular and Cellular Endocrinology. 2013 ; Vol. 383, No. 1-2. pp. 69-79.
@article{131a47ab24c441fbbd6308fa5a14e080,
title = "Linking γ-aminobutyric acid A receptor to epidermal growth factor receptor pathways activation in human prostate cancer",
abstract = "Neuroendocrine (NE) differentiation has been attributed to the progression of castration-resistant prostate cancer (CRPC). Growth factor pathways including the epidermal growth factor receptor (EGFR) signaling have been implicated in the development of NE features and progression to a castration-resistant phenotype. However, upstream molecules that regulate the growth factor pathway remain largely unknown. Using androgen-insensitive bone metastasis PC-3 cells and androgen-sensitive lymph node metastasis LNCaP cells derived from human prostate cancer (PCa) patients, we demonstrated that γ-aminobutyric acid A receptor (GABAAR) ligand (GABA) and agonist (isoguvacine) stimulate cell proliferation, enhance EGF family members expression, and activate EGFR and a downstream signaling molecule, Src, in both PC-3 and LNCaP cells. Inclusion of a GABAAR antagonist, picrotoxin, or an EGFR tyrosine kinase inhibitor, Gefitinib (ZD1839 or Iressa), blocked isoguvacine and GABA-stimulated cell growth, trans-phospohorylation of EGFR, and tyrosyl phosphorylation of Src in both PCa cell lines. Spatial distributions of GABAAR α1 and phosphorylated Src (Tyr416) were studied in human prostate tissues by immunohistochemistry. In contrast to extremely low or absence of GABAAR α1-positive immunoreactivity in normal prostate epithelium, elevated GABAAR α1 immunoreactivity was detected in prostate carcinomatous glands. Similarly, immunoreactivity of phospho-Src (Tyr416) was specifically localized and limited to the nucleoli of all invasive prostate carcinoma cells, but negative in normal tissues. Strong GABAAR α1 immunoreactivity was spatially adjacent to the neoplastic glands where strong phospho-Src (Tyr416)-positive immunoreactivity was demonstrated, but not in adjacent to normal glands. These results suggest that the GABA signaling is linked to the EGFR pathway and may work through autocrine or paracine mechanism to promote CRPC progression.",
keywords = "γ-Aminobutyric acid receptor, Epidermal growth factor, Prostate cancer, Src",
author = "Weijuan Wu and Qing Yang and Fung, {Kar Ming} and Humphreys, {Mitchell R.} and Brame, {Lacy S.} and Amy Cao and Fang, {Yu Ting} and Shih, {Pin Tsen} and Kropp, {Bradley P.} and Lin, {Hsueh Kung}",
year = "2013",
month = "12",
day = "1",
doi = "10.1016/j.mce.2013.11.017",
language = "English",
volume = "383",
pages = "69--79",
journal = "Molecular and Cellular Endocrinology",
issn = "0303-7207",
publisher = "Elsevier Ireland Ltd",
number = "1-2",

}

Linking γ-aminobutyric acid A receptor to epidermal growth factor receptor pathways activation in human prostate cancer. / Wu, Weijuan; Yang, Qing; Fung, Kar Ming; Humphreys, Mitchell R.; Brame, Lacy S.; Cao, Amy; Fang, Yu Ting; Shih, Pin Tsen; Kropp, Bradley P.; Lin, Hsueh Kung.

In: Molecular and Cellular Endocrinology, Vol. 383, No. 1-2, 01.12.2013, p. 69-79.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Linking γ-aminobutyric acid A receptor to epidermal growth factor receptor pathways activation in human prostate cancer

AU - Wu, Weijuan

AU - Yang, Qing

AU - Fung, Kar Ming

AU - Humphreys, Mitchell R.

AU - Brame, Lacy S.

AU - Cao, Amy

AU - Fang, Yu Ting

AU - Shih, Pin Tsen

AU - Kropp, Bradley P.

AU - Lin, Hsueh Kung

PY - 2013/12/1

Y1 - 2013/12/1

N2 - Neuroendocrine (NE) differentiation has been attributed to the progression of castration-resistant prostate cancer (CRPC). Growth factor pathways including the epidermal growth factor receptor (EGFR) signaling have been implicated in the development of NE features and progression to a castration-resistant phenotype. However, upstream molecules that regulate the growth factor pathway remain largely unknown. Using androgen-insensitive bone metastasis PC-3 cells and androgen-sensitive lymph node metastasis LNCaP cells derived from human prostate cancer (PCa) patients, we demonstrated that γ-aminobutyric acid A receptor (GABAAR) ligand (GABA) and agonist (isoguvacine) stimulate cell proliferation, enhance EGF family members expression, and activate EGFR and a downstream signaling molecule, Src, in both PC-3 and LNCaP cells. Inclusion of a GABAAR antagonist, picrotoxin, or an EGFR tyrosine kinase inhibitor, Gefitinib (ZD1839 or Iressa), blocked isoguvacine and GABA-stimulated cell growth, trans-phospohorylation of EGFR, and tyrosyl phosphorylation of Src in both PCa cell lines. Spatial distributions of GABAAR α1 and phosphorylated Src (Tyr416) were studied in human prostate tissues by immunohistochemistry. In contrast to extremely low or absence of GABAAR α1-positive immunoreactivity in normal prostate epithelium, elevated GABAAR α1 immunoreactivity was detected in prostate carcinomatous glands. Similarly, immunoreactivity of phospho-Src (Tyr416) was specifically localized and limited to the nucleoli of all invasive prostate carcinoma cells, but negative in normal tissues. Strong GABAAR α1 immunoreactivity was spatially adjacent to the neoplastic glands where strong phospho-Src (Tyr416)-positive immunoreactivity was demonstrated, but not in adjacent to normal glands. These results suggest that the GABA signaling is linked to the EGFR pathway and may work through autocrine or paracine mechanism to promote CRPC progression.

AB - Neuroendocrine (NE) differentiation has been attributed to the progression of castration-resistant prostate cancer (CRPC). Growth factor pathways including the epidermal growth factor receptor (EGFR) signaling have been implicated in the development of NE features and progression to a castration-resistant phenotype. However, upstream molecules that regulate the growth factor pathway remain largely unknown. Using androgen-insensitive bone metastasis PC-3 cells and androgen-sensitive lymph node metastasis LNCaP cells derived from human prostate cancer (PCa) patients, we demonstrated that γ-aminobutyric acid A receptor (GABAAR) ligand (GABA) and agonist (isoguvacine) stimulate cell proliferation, enhance EGF family members expression, and activate EGFR and a downstream signaling molecule, Src, in both PC-3 and LNCaP cells. Inclusion of a GABAAR antagonist, picrotoxin, or an EGFR tyrosine kinase inhibitor, Gefitinib (ZD1839 or Iressa), blocked isoguvacine and GABA-stimulated cell growth, trans-phospohorylation of EGFR, and tyrosyl phosphorylation of Src in both PCa cell lines. Spatial distributions of GABAAR α1 and phosphorylated Src (Tyr416) were studied in human prostate tissues by immunohistochemistry. In contrast to extremely low or absence of GABAAR α1-positive immunoreactivity in normal prostate epithelium, elevated GABAAR α1 immunoreactivity was detected in prostate carcinomatous glands. Similarly, immunoreactivity of phospho-Src (Tyr416) was specifically localized and limited to the nucleoli of all invasive prostate carcinoma cells, but negative in normal tissues. Strong GABAAR α1 immunoreactivity was spatially adjacent to the neoplastic glands where strong phospho-Src (Tyr416)-positive immunoreactivity was demonstrated, but not in adjacent to normal glands. These results suggest that the GABA signaling is linked to the EGFR pathway and may work through autocrine or paracine mechanism to promote CRPC progression.

KW - γ-Aminobutyric acid receptor

KW - Epidermal growth factor

KW - Prostate cancer

KW - Src

UR - http://www.scopus.com/inward/record.url?scp=84891096632&partnerID=8YFLogxK

U2 - 10.1016/j.mce.2013.11.017

DO - 10.1016/j.mce.2013.11.017

M3 - Article

C2 - 24296312

AN - SCOPUS:84891096632

VL - 383

SP - 69

EP - 79

JO - Molecular and Cellular Endocrinology

JF - Molecular and Cellular Endocrinology

SN - 0303-7207

IS - 1-2

ER -